Literature DB >> 32125939

De-Escalating Treatment of Low-Risk Breast Ductal Carcinoma In Situ.

Matteo Lazzeroni1, Andrea DeCensi1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32125939     DOI： 10.1200/JCO.20.00124

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

Review 1.  Diagnosis of ductal carcinoma in situ in an era of de-escalation of therapy.

Authors:  Stuart J Schnitt
Journal:  Mod Pathol       Date:  2020-09-09       Impact factor: 7.842

Review 2.  De-Escalating the Management of In Situ and Invasive Breast Cancer.

Authors:  Fernando A Angarita; Robert Brumer; Matthew Castelo; Nestor F Esnaola; Stephen B Edge; Kazuaki Takabe
Journal:  Cancers (Basel)       Date:  2022-09-20       Impact factor: 6.575

3.  A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast.

Authors:  Luca Nicosia; Anna Carla Bozzini; Silvia Penco; Chiara Trentin; Maria Pizzamiglio; Matteo Lazzeroni; Germana Lissidini; Paolo Veronesi; Gabriel Farante; Samuele Frassoni; Vincenzo Bagnardi; Cristiana Fodor; Nicola Fusco; Elham Sajjadi; Enrico Cassano; Filippo Pesapane
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.